Target intelligence / Profile preview

Osteoclast bone-resorbing machinery

Molecular classification
Enzyme, Other
01

Overview

Osteoclasts are specialized multinucleated cells derived from the monocyte-macrophage lineage that are responsible for the degradation of mineralized bone matrix [1]. The bone-resorbing machinery of these cells is a critical therapeutic target in the management of osteoradionecrosis (ORN) and other metabolic bone diseases [2]. In the PENTOCLO protocol, clodronate or substituted bisphosphonates are utilized to inhibit this machinery and induce osteoclast apoptosis, thereby halting pathological bone resorption [3]. Clodronate specifically acts as a pro-drug that is converted into cytotoxic ATP metabolites within the cell, while nitrogenous bisphosphonates interfere with the mevalonate pathway [1][5]. This targeted approach, when combined with the antioxidant effects of tocopherol and the anti-fibrotic properties of pentoxifylline, promotes the healing of radiation-damaged bone tissue [2][4]. Understanding this target is essential for optimizing treatments that address the complex interplay of vascular insufficiency and bone turnover in necrotic bone conditions [4]. References: [1] Rogers MJ, et al. Bone. 2011; [2] Delanian S, et al. Radiation Oncology. 2011; [3] Frith JC, et al. JBMR. 1997; [4] Lyons A, et al. Br J Oral Maxillofac Surg. 2015; [5] Russell RG. Pediatrics. 2007.

Other names
OsteoclastBone-resorbing machineryOsteoclast-mediated bone resorptionOsteoclasts / bone-resorbing machinery – clodronate or substituted bisphosphonate component in modified PENTOCLO
02

Mechanism of action

Clodronate is a non-nitrogenous bisphosphonate that is metabolized by osteoclasts into non-hydrolyzable ATP analogs (adenosine 5'-(beta,gamma-dichloromethylene) triphosphate), which inhibit mitochondrial adenine nucleotide translocase (ANT), leading to osteoclast apoptosis [1][3]. Substituted nitrogenous bisphosphonates, which may be used in modified PENTOCLO protocols, inhibit farnesyl pyrophosphate synthase (FPPS) in the mevalonate pathway, preventing the prenylation of small GTPases (e.g., Rho, Rac, Rab) essential for the formation of the ruffled border and osteoclast survival [1][5].

03

Biological functions

Bone resorptionApoptosisBone remodelingCellular metabolism
04

Disease associations

OsteoradionecrosisOsteoporosisPaget's disease of boneBone metastasisHypercalcemia of malignancy
05

Safety considerations

Osteonecrosis of the jaw (ONJ)Atypical femoral fractures (AFF)Gastrointestinal irritationRenal impairmentHypocalcemia
06

Interacting drugs

Clodronate

4 more in the full profile.

07

Biomarkers

C-terminal telopeptide (CTX)N-terminal telopeptide (NTX)Bone-specific alkaline phosphatase (BSAP)Tartrate-resistant acid phosphatase 5b (TRACP-5b)

Beyond the preview

Go deeper on Osteoclast bone-resorbing machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteoclast bone-resorbing machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call